CPT code 45382 – Colonoscopy with control of bleeding

Key takeaways

CPT code 45382 covers flexible colonoscopy with control of active bleeding anywhere from the rectum to the cecum, by any hemostasis method.

The code requires documented active bleeding at the procedure site, not prophylactic treatment of a non-bleeding lesion.

Diagnostic colonoscopy 45378 is never reported alongside 45382, and modifier 59 or XS applies only between two therapeutic codes at distinct sites.

A Medicare screening that converts to bleeding control is billed as 45382 with modifier PT and the screening diagnosis.

Pabau’s claims management software submits and tracks 45382 claims, with eligibility checks and ERA posting in one workflow.

CPT code 45382: official descriptor and procedure overview

CPT code 45382 is defined by the American Medical Association (AMA) as “Colonoscopy, flexible; with control of bleeding, any method.” Colonoscopy examines the entire colon, from the rectum to the cecum, and may include the terminal ileum. That scope is shared by every code in the 45378-45398 colonoscopy family.

“Any method” is the operative phrase. The code applies regardless of which hemostasis technique the endoscopist uses, provided active bleeding is identified and treated during the same session. Multiple methods used in a single session still bill as one unit of 45382.

When 45382 applies

• Active bleeding identified during flexible colonoscopy anywhere in the colon, rectum to cecum (and terminal ileum if examined)
• Hemostasis achieved by thermal coagulation, injection therapy, mechanical device, or any combination
• Single session, where multiple methods used for the same bleeding site remain one code
• Inpatient, outpatient facility, and ambulatory surgery center (ASC) settings are all valid

The code does not apply when the endoscopist treats a lesion prophylactically that is not actively bleeding. That documentation mistake is a common audit trigger for 45382 claims.

Procedure techniques covered under CPT code 45382 bleeding control

Because 45382 covers “any method,” knowing what qualifies helps coders confirm the documentation is complete before submission. The operative report must name the specific technique used.

CPT 45382 vs. 45378, 45379, 45380, and 45385: when to use each code

Each code in the colonoscopy family represents a distinct intervention, and choosing the wrong one triggers NCCI bundling edits or undercoding. The most frequent mix-up is reporting diagnostic colonoscopy 45378 on the same claim as a therapeutic code.

Critical bundling rule: When post-polypectomy bleeding is treated during the same session as 45385, the hemostasis is included in 45385. You cannot add 45382 on top of 45385 for the same site.

Bleeding found at a separate, distinct site and controlled independently is different. There, modifier XS or 59 may allow separate billing of 45382 and 45385. Verify the current National Correct Coding Initiative (NCCI) edit table before submitting, because these edits change quarterly. The decision path below puts these rules in the order a coder should apply them.

Medicare and Medicaid reimbursement rates for CPT 45382

Medicare reimbursement for CPT code 45382 is calculated from the Medicare Physician Fee Schedule (MPFS). Rates change on January 1 each year, so verify current figures through the CMS Physician Fee Schedule lookup tool for the applicable payment year. The figures below reflect approximate 2025 national rates as a reference point.

Verify exact RVU values and conversion factors using the FastRVU 2026 RVU lookup tool, which pulls directly from CMS data. Medicaid rates vary by state, so contact the relevant state Medicaid agency for the authoritative fee schedule. Commercial payer rates (UnitedHealthcare, Aetna, BCBS) are contract-specific and cannot be generalized.

ICD-10 diagnosis codes that support CPT 45382

The paired ICD-10-CM diagnosis code must reflect active gastrointestinal bleeding documented at the time of the procedure. A mismatch between the ICD-10 code and the operative report is a frequent denial trigger for 45382 claims. Confirm codes are current for the applicable fiscal year edition using the CDC/NCHS ICD-10-CM resources.

The diagnosis code must link directly to the operative finding. If the pre-procedure diagnosis was “hematochezia” but the scope found and controlled a diverticular bleed, update the claim to K57.31. Use K57.33 only when the endoscopist also documents diverticulitis. Submitting the pre-procedure symptom code after a definitive finding was documented is a common error that delays payment.

Documentation requirements for CPT 45382

The operative or endoscopy report is the primary documentation source for 45382 claims. Payers audit this code closely, because brief notes often blur the line between active bleeding control and prophylactic treatment. Sound medical billing workflows start with a documentation checklist the endoscopist completes before the scope is withdrawn.

The report must contain all of the following:

1. Active bleeding confirmed: an explicit statement that bleeding was found at the procedure site. For example, “active oozing from a diverticular orifice at 35 cm from the anal verge”
2. Anatomical location: distance from the anal verge or landmark (cecum, hepatic flexure, splenic flexure, sigmoid, rectum)
3. Hemostasis method: specific technique(s) used and the result (e.g., “APC applied at 40W x 3 pulses; hemostasis achieved”)
4. Extent of scope insertion: confirmation that the scope reached the cecum or the extent of insertion if incomplete
5. Patient response: documentation that hemostasis was confirmed before scope withdrawal
6. Medical necessity statement: if bleeding was acute (emergency or urgent), note the clinical indication (e.g., hemodynamic instability, drop in hemoglobin)

What disqualifies 45382: documenting “polypectomy site cauterized to prevent bleeding” or “APC applied to angiodysplasia for prophylaxis” does not support 45382. The code requires active, identified bleeding that is being controlled, not prevention of potential future bleeding.

G0105 and G0121: screening vs. therapeutic colonoscopy coding

When a Medicare screening colonoscopy converts to a therapeutic procedure with hemorrhage control, the claim moves from the screening HCPCS code to 45382. The conversion changes both the coding and what the patient owes.

CMS guidance distinguishes the two screening codes as follows:

• G0105 (high-risk screening colonoscopy): for Medicare beneficiaries at high risk for colorectal cancer (personal or family history of polyps or colorectal cancer, inflammatory bowel disease)
• G0121 (average-risk screening colonoscopy): for Medicare beneficiaries not at high risk, typically every 10 years

When the endoscopist identifies and controls active bleeding during a procedure that began as a screening exam, G0105 or G0121 comes off the claim. For Medicare, report 45382 with modifier PT and keep the screening diagnosis on the claim. Modifier PT tells the contractor the session started as a colorectal cancer screening.

Patients still owe coinsurance on these converted procedures, but less over time. Under Section 122 of the Consolidated Appropriations Act of 2021, the coinsurance is 15% for 2023 through 2026 and 10% for 2027 through 2029. From 2030 it drops to 0%. The CMS guidance on the coinsurance phase-down sets out the schedule.

Modifiers for CPT code 45382

Choosing the right modifier for 45382 prevents bundling denials and supports the medical necessity case when payers question multiple same-session codes. For superbill generation and claim assembly, coders need five modifiers on hand for GI colonoscopy sessions.

Modifier 59 vs. XS: CMS introduced the -X{EPSU} modifiers (XE, XS, XP, XU) as more specific alternatives to modifier 59. For bleeding control at a site separate from another therapeutic colonoscopy service, Medicare Administrative Contractors prefer XS (separate structure) over the generic modifier 59. Check your MAC’s current guidance before choosing between them.

Prior authorization and payer requirements

Prior authorization requirements for CPT code 45382 vary by payer, plan type, and clinical urgency. Confirm insurance eligibility verification and authorization status before every elective procedure. An unverified authorization is the fastest path to a non-coverage denial.

• Medicare (traditional): prior authorization is not required for 45382 under original Medicare Part B
• Medicare Advantage (managed Medicare): many MA plans require prior authorization, so check the specific plan’s PA list, which differs from original Medicare
• Medicaid managed care: most state managed Medicaid plans require prior authorization. Criteria often follow eviCore or similar third-party guidelines that ask for evidence of active or recent GI bleeding
• Commercial payers (UHC, Aetna, BCBS): requirements vary by contract and plan tier, so verify through the payer portal before scheduling

Emergent or urgent procedures: when the procedure is performed emergently for acute GI hemorrhage, most payers allow retrospective authorization within 24-72 hours. Document the emergent nature explicitly in the operative report and flag the claim accordingly. Missing the payer’s retrospective authorization window results in denial regardless of clinical appropriateness.

Common claim denial reasons for CPT 45382 and how to avoid them

Denials for CPT code 45382 cluster around three root causes: incomplete documentation, bundling errors, and authorization failures. Strong denial management workflows catch these before submission rather than after. Review our medical billing denial codes reference for the CARC/RARC codes payers use to explain 45382 rejections.

For clean claim submission, run 45382 through your clearinghouse’s pre-submission scrubber. A scrubber catches format errors and payer edits. It cannot tell whether the operative note documents active bleeding, so the checklist below still decides whether the claim holds up.

How claims management software keeps CPT 45382 claims moving

Many GI billing teams still assemble a 45382 claim by hand. They copy codes from the endoscopy report into a clearinghouse portal, then check eligibility and remittances in yet another screen.

Pabau, the practice management and billing platform we build, pulls the record data your team has already entered into a pre-filled claim. Its claims management software then submits and tracks the claim to thousands of US payers via Claim.MD. Eligibility checks and ERA posting run in the same workflow.

Coding judgment stays with your coders. Pabau does not choose the code or audit modifiers, so the documentation rules above still decide whether 45382 is supportable. What drops away is the re-keying between systems, which leaves your billers more time for the denials that need a person.

Simplify GI billing with Pabau

Pabau’s claims management software submits and tracks claims to thousands of US payers via Claim.MD. Eligibility checks and ERA posting run in the same workflow for GI and multi-specialty practices.

Book a demo

Conclusion

A 45382 claim stands or falls on one sentence in the operative note: that bleeding was active when the endoscopist found it. Without that sentence, no modifier or diagnosis code rescues the claim.

The bundling rules are just as fixed. Drop 45378 whenever 45382 is reported, keep post-polypectomy hemostasis inside 45385, and save XS or 59 for a separate bleed at a distinct site. On a converted Medicare screening, modifier PT protects the patient’s reduced coinsurance.

Build those checks into the endoscopy report template, and the claim is right before it reaches billing. Book a demo to see how Pabau submits and tracks GI claims so your team spends less time re-keying them.

Continue your research

Need to understand how claims reach payers? Medical claims clearinghouse guide explains the 837P submission pathway and how clearinghouse edits catch errors before adjudication.

Struggling with ERA reconciliation after 45382 claims? Electronic remittance advice (ERA) workflows covers 835 file processing and how to match payments to claims.

Want a framework for reducing first-pass denials? Revenue cycle management guide outlines the workflow stages where GI practices typically lose recoverable revenue.

Coding the polyp removal in the same session? CPT code 45385 covers snare polypectomy and how it interacts with bleeding control.

Sampling tissue instead of treating a bleed? CPT code 45380 explains colonoscopy with biopsy and its documentation requirements.

Frequently asked questions